Fierce Healthcare6h
Evernorth expands coverage of NeuroStar depression therapy to adolescents
Cigna's Evernorth unit is expanding coverage for Neuronetics' therapy for depression to adolescents. | Cigna's Evernorth unit ...
Tharimmune Announces Positive FDA Feedback on NDA Path for TH104 for Prophylaxis of Respiratory and/or CNS Depression for Ultrapotent Opioid Exposure
Received positive feedback on New Drug Application submission via the 505(b)(2) pathway-Company leveraging existing human pharmacokinetic data ...
Labiotech.eu7d
Depression drug trials are failing—and placebos are to blame
Discover recent clinical trial failures in depression and explore potential pathways for advancing antidepressant drug ...
Exomind device promises to zap depression, lift mental fog
A NYC dermatologist is now offering brain treatments with an Exomind device, which is said to be a high-tech fix for ...
MPR7d
Magstim TMS System Cleared for Adolescents With Major Depressive Disorder
The Horizon 3.0 TMS Therapy System is a computerized, noninvasive medical device that directs electrical currents at different regions of the cerebral cortex.
Psychology Today4d
Do Weight-Loss Medications Affect Mental Health?
Drugs like Ozempic, Wegovy, and Saxenda have become hugely popular. But could they cause psychological side effects in their ...
Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression
Policy update increases access for millions covered by Evernorth Health ServicesMALVERN, Pa., March 31, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial ...